Rajesh Thakker is the May Professor of Medicine at the University of Oxford. His main research interests include the molecular basis of disorders of calcium homeostasis and he has authored over 350 publications, which have included peer-reviewed papers in the New England Journal of Medicine, Nature, Nature Genetics, Journal of Clinical Investigation and Lancet Journals. He is a Consultant Endocrinologist who provides expertise in the fields of neuroendocrine tumours (NETs), and disorders of calcium and phosphate metabolism. He was previously Professor of Medicine at The Royal Postgraduate Medical School, The Hammersmith Hospital, London, until 1999, when he took up his present position in Oxford. He has served on the MRC Physiological Medicine and Infections Board (2000-2005), the Council for the Society for Endocrinology (2003-2006), and as Chairman of the National Institute of Health Research (NIHR) / MRC Efficacy and Mechanisms Evaluations (EME) Board (2008-2016). He has been the recipient of many prizes which include: Young Investigator Award from the American Society for Bone and Mineral Research (ASBMR), USA (1988); the Raymond-Horton Smith Prize (Cambridge University, UK) (1994); the Society for Endocrinology (UK) medal (1995); the European Journal of Endocrinology Prize (EFES) (1998); WPU Jackson Memorial Lecture, Society for Endocrinology, Metabolism, and Diabetes in South Africa (SEMSDA) (1998); the Graham Bull Prize from the Royal College of Physicians (UK) (1999); Bernard Pimstone Memorial Lecture, SEMSDA (2003); the Parathyroid Medal from the Fondazione Raffaella Becagli (FIRMO) (2012); the Jack W. Coburn Endowed Lectureship from the American Society of Nephrology (2012); the Louis V Avioli Founder’s Award from the ASBMR (USA) (2009); the International Research Prize from the Austrian Society for Bone and Mineral Research (2015); and the Dale Medal from the Society for Endocrinology (UK) (2015). Professor Thakker was elected to the Fellowship of the Royal Society (FRS) in 2014.
Recent Selected Publications
Howles SA, Hannan FM, Babinsky VN, Rogers A, Gorvin CM, Rust N, Richardson T, McKenna M, Nesbit MA, Thakker RV (2016). Cinacalcet Rectifies Symptomatic Hypercalcaemia Caused by AP2S1 Mutations. New England Journal of Medicine 374: 1396-1398.
Newey P, Gorvin C, Cleland S, Willberg C, Bridge M, Azharuddin M, Drummond R, van der Merwe P, Klenerman P, Bountra C, Thakker RV (2013). Mutant prolactin receptor and familial hyperprolactinemia. New England Journal of Medicine 369: 2012-2020.
Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, Rust N, Hobbs MR, Heath H III, Thakker RV (2013). Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia. New England Journal of Medicine 368: 2476-86.